The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read our statement on the NICE ruling on abiraterone and find out more about our discovery of a key mutation which causes a childhood kidney cancer.
The Institute of Cancer Research, London, has issued a statement following the rejection, by NICE, of abiraterone before chemotherapy.
Mutations in a gene that helps regulate when genes are switched on and off in cells have been found to cause rare cases of Wilms tumour, the most common kidney cancer occurring in children.
Professor Kevin Harrington explains how viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation.
Our Development Office is here to help you support our work, however you choose to do so
Our PhD students make a real contribution to defeating cancer while working full-time in the lab
Dr Chris Bakal is doing fundamental research into cancer – vital to finding new ways of attacking it.
Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Dr Angela Kukula works with pharmaceutical companies to help develop new cancer drugs, using her expertise to negotiate collaborations between the ICR and industry
We run clinical trials with The Royal Marsden – taking our lab results right to the bedside
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
Our Interim Chief Executive, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
The ICR’s research aims to learn more about cancer genetics and tumour biology – and use that information in discovering new treatments.
Bringing our imaging experts together under one roof in our new centre could help us develop better ways of imaging, diagnosing and treating cancer.
Our PhD students conduct world-class research projects, while our MSc in Clinical Oncology teaches about the latest in clinical practice.
Find out more about the aims and achievements of our eight scientific divisions.
RT @CR_UK: This month's podcast hero: Prof Andy Pearson from @ICR_London, running a vital neuroblastoma trial: http://t.co/i9MOhRhkRC
Doing cancer research – In pictures
The babies who cure themselves of cancer
How our new website will open a window to the ICR's science